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ABSTRACT
Exonic splicing enhancer (ESE) sequences are
bound by serine & arginine-rich (SR) proteins, which
in turn enhance the recruitment of splicing factors. It
was inferred from measurements of splicing around
twenty years ago that Drosophila doublesex ESEs
are bound stably by SR proteins, and that the bound
proteins interact directly but with low probability with
their targets. However, it has not been possible with
conventional methods to demonstrate whether mam-
malian ESEs behave likewise. Using single molecule
multi-colour colocalization methods to study SRSF1-
dependent ESEs, we have found that that the propor-
tion of RNA molecules bound by SRSF1 increases
with the number of ESE repeats, but only a single
molecule of SRSF1 is bound. We conclude that initial
interactions between SRSF1 and an ESE are weak
and transient, and that these limit the activity of a
mammalian ESE. We tested whether the activation
step involves the propagation of proteins along the
RNA or direct interactions with 3′ splice site compo-
nents by inserting hexaethylene glycol or abasic RNA
between the ESE and the target 3′ splice site. These
insertions did not block activation, and we conclude
that the activation step involves direct interactions.
These results support a model in which regulatory
proteins bind transiently and in dynamic competition,
with the result that each ESE in an exon contributes
independently to the probability that an activator pro-
tein is bound and in close proximity to a splice site.
INTRODUCTION
The high point in studies on the mechanisms of action of
exonic splicing enhancer sequences was reached in 1998.
It had been shown previously that sequences in alterna-
tive exons were required for their inclusion (1–5), and in
mammals these sequences had been mapped to relatively
short, purine-rich motifs (6–8). These motifs were found to
be bound by SR proteins (8–10). SR proteins have one or
twoRNA recognitionmotif (RRM)-typeRNA-binding do-
mains and a C-terminal RS domain, rich in arginine-serine
dipeptides, that is subject to extensive phosphorylation (11–
13). The binding of these proteins to ESEs was shown to
stimulate splicing, splicing complex assembly and binding
of U2 snRNPs and U2-associated proteins U2AF65 and
U2AF35 (8,14–16).Moreover, SR proteins were shown also
to interact directly with U2AF35 and this interaction was
shown to mediate the effects of ESEs on the splicing of
an upstream intron (17,18). These observations led to two
models for themechanisms of action of ESEs. ESEs that are
within 100 nts or so of the 3’SS were proposed to work by
binding of an SR protein to the ESE and propagation of the
complex by cooperative interactions with further SR pro-
teins until interactions with U2AFwere possible; ESEs that
are regulated, such as the repeated elements in Drosophila
dsx exon 4 (dsxREs) that depend on the proteins Tra and
Tra2, might form stable multi-protein complexes and inter-
act directly over greater distances by 3D-diffusion (looping)
(18).
These models resolve the mechanisms of action of ESEs
into two steps, either of which might be limiting or regu-
lated. The irst is binding to the ESE (Figure 1A–D); the
second is the step in which the ESE-bound SR protein ac-
tivates its target splice site (Figure 1E and F). The mod-
els were tested indirectly in two important papers in 1998
by following the rates of splicing dependent on the dsxREs
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Figure 1. Elementary processes representing possible SR protein binding
(A–D) and activation (E and F) steps by which ESEs stimulate 3′ splice site
usage. (A) SR proteins bind stably, with multiple occupancy of tandemly-
repeated ESEs, and the probability of subsequent interactions by mecha-
nismsE or F is limiting. Solid blue line, pre-mRNA; red oval, SRSF1; other
ovals, components at the 3’SS (U2AF, U2 snRNP, etc.); dashed lines, low
probability interactions. (B) SR proteins bind stably, with multiple occu-
pancy of tandemly-repeated ESEs, and are able to interact with multiple
targets, each of which has an approximately equal effect on the rate. (C)
SR protein binding is cooperative. (D) The probability of binding by an
SR protein is very low and each site contributes independently. (E) Acti-
vation involves direct contact by three-dimensional diffusion between an
ESE-bound SR protein and a 3’SS component; the intervening RNA is
looped out. (F) Activation involves processes that maintain contact with
the RNA between the ESE and the 3’SS, such as propagation of SR pro-
tein complexes or scanning along the RNA (for example, in conjunction
with a helicase).
(19,20). The proportion of dsx pre-mRNA that had spliced
in vitro in a given time was shown to increase with the ad-
dition of Tra/Tra2, but the level of splicing asymptotically
approached a maximum with increasing concentrations of
protein. Assuming that the maximum level of splicing was
a direct function of dsxRE occupancy and not, for exam-
ple, the result of limiting solubility or aggregation at higher
protein concentrations, it was inferred that the dsxREs had
become saturated (20). Since the concentration of Tra/Tra2
required for half-maximal splicing did not depend on the
number of dsxREs, it was concluded that each dsxRE was
independent. The level of splicing reached under saturating
conditionswas linearly dependent on the number of dsxREs
present (1–6, distributed along the exon 300–600 nts from
the 3’SS), from which it was inferred that each dsxRE ele-
ment was occupied and that the more that were occupied,
the higher the chance of activation of splicing, as if the
bound SR proteins each had a low probability of contacting
a common target (20) (Figure 1A). This interpretation was
substantiated by the use of tethered RS domains placed at
various distances downstreamof the 3’SS. The rates of splic-
ing depended on the length of the RS domain, consistent
with the existence of a common target, and declined with
distance from the 3’SS as expected if the target were being
found by looping (19). These results supported the models
shown in Figure 1A and E.
Since then, the variety of sequences known to act in
some contexts as ESEs or silencers has expanded consider-
ably, following computational analyses (21,22), systematic
screens of large sequence libraries (23,24) and the analysis
of mutations (25–29). As a result, there is a much better
understanding of the sequence preferences of the SR pro-
teins, such as the prototypical SR protein, SRSF1 (30–34).
Mapping of the transcriptome-wide binding sites by cross-
linking in vivo conirms these preferences (34–37), and some
analyses show binding sites enriched near splice sites. De-
spite this plethora of information, the limitations of all the
widely usedmethods for studying splicingmechanisms have
meant that there has been little progress in understanding
the interactions of ESEs with trans-acting factors and the
subsequent mechanisms of activation. The most informa-
tive experiments have come from the use ofRS domains that
were stably tethered to a 3′ ESE. These experiments showed
that the RS domains contacted the branchpoint of the pre-
ceding intron (38,39) and stabilized U2 base-pairing (40).
While these results support the idea of direct interactions
or looping (Figure 1E), the use of tethering meant that the
contribution of binding to the rate-determining step could
not be assessed, the numbers of SR proteins boundwere not
known so propagation (Figure 1F) could not be excluded,
and the contacts made were not, as had been expected, with
U2AF proteins. Thus, the models inferred from the rates of
Drosophila Tra/Tra2-dependent splicing are still generally
used to represent or interpret mammalian ESE activity.
Doubts about the applicability of the dsxRE model to
mammalian enhancers in general have arisen from analy-
ses of complexes forming on ESEs. Using targeted oligonu-
cleotide enhancers of splicing (TOES), we showed that
splicing eficiency increased with the number of GGA re-
peat motifs in the enhancer domain of the oligonucleotide,
consistent with the dsxRE results (41). However, extensive
investigations using conventional methods showed that the
enhancer sequence was able to form a number of differ-
ent complexes, including a G-quadruplex, and that SR pro-
tein complexes under normal conditions were only minor
components (42). This is consistent with other examples in
which the proportion of cross-linking or afinity-puriied
proteins attributable to SR proteins in enhancer complexes
has likewise been found to be very low (14,43), and sug-
gested to us that SR proteins might interact only transiently
with ESEs (42), as in the model in Figure 1D.
The best way to identify whether the limiting step in ac-
tivation by an ESE is the binding of the SR protein or its
subsequent interactions is to use multiple ESEs and test for
multiple occupancy. Concurrent occupancy would indicate
functionally stable binding and that, as with the dsxRE,
subsequent interactions are limiting (Figure 1A-C). If mul-
tiple ESEs increased the rate of splicing but this was linked
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only to increased levels of single occupancy, then the prob-
ability of binding would be limiting (Figure 1D). The use of
indirect methods, such as those used for the dsxRE, is in-
appropriate because the splicing rates do not saturate and
it is dificult to infer much from a negative result (20). Di-
rect measurement of the numbers of ESEs occupied would
be a much more deinitive approach. However, such mea-
surements cannot be made in functional splicing assays for
ESEs embedded in a pre-mRNA using conventional meth-
ods such as cross-linking, including CLIP, or afinity purii-
cation, because of the high levels of apparently non-speciic
association of SR proteins with RNA mediated by their
RS domains, because SR proteins are recruited in other
ways and because the distribution of pre-mRNAmolecules
among complexes with different numbers of molecules of
protein bound is unknowable.
Single molecule multi-colour colocalization methods
have been used extensively by this laboratory to deter-
mine directly the numbers of protein molecules bound to
a molecule of pre-mRNA in mammalian nuclear extracts
(44–47) (Figure 2) and by the laboratory ofM.Moore to fol-
low the dynamics of association and dissociation of splicing
factors in yeast extracts (48,49), providing mechanistic evi-
dence that would otherwise be unattainable. By combining
single molecule methods with the use of non-RNA linkers,
we describe a new paradigm for mammalian enhancers.
MATERIALS AND METHODS
Sequences
The transcripts comprised 225 nts of rabbit -globin exon
2 and 67 nts of intron 2, fused to human SMN2 exon 7
and 157 nts of the preceding intron as described previously
(42,50). In the control transcript, transcription terminated
at nucleotide 48 in SMN2 exon 7, excluding the 6 nts pre-
ceding the 5′ splice site.
The ESE sequences appended to nt 48 were as follows:
ESE-A, CAAGGCGGAGGAAG;
ESE-B, CACACAGGACCACACAGGAC;
ESE-C, AAAAAGAAAGAAAAAAAGAAAGAA;
ESE-D, UCAGAGGAUCAGAGGA.
Tandem repeats of ESE-A were used as described.
In all the transcripts used for the assays with non-RNA
linkers, the transcript lacked the Tra2 enhancer region
(SMN2 exon 7 nts 17–28) and ended at nt 38. The removal
of nts 17–28 shortened the exon by 12 nts, so that the ad-
dition of 12 abasic nts at the 3′ end followed by the ESE
put the ESE at the same distance relative to the 3′ splice site
as when the ESE was appended to the 3′ end as described
above.
The transcripts used for splicing and cross-linking were
prepared using T7 RNA polymerase with the cap analogue
GpppG for initiation and [-32P]GTP for elongation. The
transcripts used for cross-linking were as follows, omitting
the 5′ cap:
1 ESE, GCAAGGCGGAGGAAG;
2 ESEs, GCAAGGCGGAGGAAGCAAGGCGGAGG
AAG;
3 ESEs, GCAAGGCGGAGGAAGCAAGGCGGAGG
AAGCAAGGCGGAGGAAG;
4 ESEs, GCAAGGCGGAGGAAGCAAGGCGGAGG
AAGCAAGGCGGAGGAAGCAAGGCG-GAGGA
AG
These were puriied by denaturing gel electrophoresis and
quantiied by scintillation counting.
Synthesis and ligation of non-RNA linkers
The sequences ligated to nt 38 of SMN2 exon 7 were as fol-
lows:
UUCCUUAAAUCAAGGCGGAGGAAGCAAGGC
GGAGGAAG (exon 7 nts 39–48 + ESE-Ax2).
UUCCUUAAAU – 2HEG – CAAGGCGGAGGAAGCA
AGGCGGAGGAAG
UUCCUUAAAU – 12 abasic pd – CAAGGCGGAGGA
AGCAAGGCGGAGGAAG
UUCCUUAAAU – 12 abasic pr – CAAGGCGGAGGA
AGCAAGGCGGAGGAAG
The synthesis of the linkers is described in detail else-
where (Reichenbach et al., ms in preparation). In brief,
TOM-Protected RNA phosphoramidites, HEG spacer
phosphoramidite and CPG supports loaded with standard
nucleosides were purchased from LINK Technologies Ltd
(Bellshill, UK) and Cambio Ltd. (Cambridge, UK). Abasic
phosphoramidites were synthesized based on methods re-
ported in the literature (51,52). RNA oligonucleotides were
synthesized using standard solid phase oligonucleotide syn-
thesis protocols on an ABI 394 synthesizer. The reaction
time for each individual coupling was 10 min. The crude
oligonucleotides were puriied by gel electrophoresis before
ligation to the transcripts with 20 nt DNA oligonucleotide
splints and T4 RNA ligase 2 (53).
Labelling RNA at the 5′ end
Substrate RNAs for single molecule detection were tran-
scribed in the presence of 10 mM guanosine-5′-O-
monophosphorothioate (BioLog), and the 5′ end was la-
belled using 5′ Cy5-maleimide (54), as described (47).
Splicing and analysis of complexes
The HeLa cell nuclear extract containing mEGFP-SRSF1
and mCherry-U1A was prepared (55) and the relative lev-
els of exogenous and endogenous proteins were charac-
terized by western blotting and detection with a luores-
cent secondary antibodies (IRDye 680LT, LI-COR 926–
68020; IRDye 800CW,LI-COR926–32211). Splicing assays
and native gel electrophoresis of splicing complexes were
done as reported previously (45). Splicing levels were taken
as the molecular ratio of mRNA/(mRNA + pre-mRNA),
after allowing for the number of radioactive nucleotides
in each species. For cross-linking reactions, the ESE tran-
scripts were incubated in 10 l in splicing conditions for 15
min, then irradiated with a short-wave SpotCure (UVP) for
2 min and incubated with 2 g RNase A and 5 U RNase
T1 before electrophoresis and transfer onto nitrocellulose.
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Figure 2. An outline of single molecule multicolour colocalization. (A) Representative views of a ield of view showing the accumulated emission upon
excitation at 640 nm (forRNA labelledwithCy5, red spots) and 488 nm (formEGFP-SRSF1, green spots). Datawas collected by emCCD from excitation at
640 nm for 50 frames of 50 ms and at 488 nm for 250 frames of 50 ms. Cy5-labelled RNA had been incubated in nuclear extract expressing mEGFP-SRSF1
under conditions allowing complex A formation before dilution and injection onto the slide surface for detection by total internal relection luorescence
microscopy. Colocalized RNA and protein molecules are shown by circles. (B) Time courses of mEGP luorescence from representative spots. Irreversible
drops in the emission intensity are caused by bleaching of a single molecule of mEGFP. These are direct screen images and the ordinate (intensity per 50 ms
frame) is re-scaled for each spot. (C) Diagrams showing for each molecule the number of mEGFP-SRSF1 molecules associated with the RNA, deduced
from the bleaching proile. (D) The spots are classiied and each contributes one RNA molecule to the classes represented in the histogram.
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Sample preparation
Cover slips fromMenzel-Gla¨ser (22mm× 50mm, #1) were
soaked in 1 M KOH for four hours before being washed
with water, sonicated, dried under a nitrogen stream and
cleaned in an argon plasma (MiniFlecto-PC-MFC, Gala
Instruments) for 5 times 5 min. Sample chambers were
formed with double-sided tape and a second cover slip.
Splicing reactions were prepared with 50% nuclear extract,
3.2 mMMgCl2, 50 mMmonopotassium glutamate, 20 mM
phosphocreatine, 1.5 mM ATP, 20 mM Hepes pH 7.5 and
3 units RNase OUT (Invitrogen). A 2′-O-methyl oligonu-
cleotide complementary to U6 snRNA was added at 1 M
to block splicing at complex A (45,56). The reaction mix-
tures were pre-incubated for 15 min at 30◦C before pre-
mRNA was added at a inal concentration of 62.5 nM and
incubated for a further 15 min at 30◦C. Samples were di-
luted in 40 mM Hepes pH 7.5, 3.2 mM MgCl2, 50 mM
monopotassium glutamate, 50 mM KCl, 0.1 mM EDTA
and 0.5 mM DTT, loaded into the sample chamber and in-
cubated for 5 min.
Data acquisition and analysis
A home-built objective-based total internal relection lu-
orescence microscope was used for the single-molecule ex-
periments. The central regions of both the laser beam and
the CCD chipwere used to reduce intensity variation. A sta-
ble focus was achieved by active feedback from the relected
beam. Nine ields were acquired in succession automati-
cally, and from each experiment∼50 ields in total were ac-
quired. Each ield was obtained by collection of 50 frames,
each of 50 ms, with excitation at 633 nm, followed by the
collection of 250 frames with excitation at 488 nm. The peri-
ods of irradiation resulted in the complete bleaching of Cy5
(pre-mRNA) andmEGFP in each case. Recording was con-
tinuous, minimizing the possibility of unrecorded bleaching
of mEGFP during the switch between lasers. Each SRSF1
experiment was done on three separate occasions.
Data analysis
The data were analyzed using a MATLAB program.
Spots produced by luorescence were identiied by detecting
squares in which the maximum pixel intensity exceeded the
mean by a threshold value, tested for the presence of only a
single peak, and required to conform to a Gaussian distri-
bution in each dimension. The use of maximum intensities
during the recording period ensures that mEGFPmolecules
that were in a dark state at any point, even repeatedly, would
be detected during the 12.5 s of irradiation at 488 nm be-
cause the dark state lifetime of mEGFP is only 1–2 s (57–
59). Chromatic aberrations were corrected by a linear trans-
formation, using parameters from a test molecule labelled
with two luorophores. Steps in the bleaching proile were
identiied using a recursive Bayesian strategy (Jobbins et al.,
submitted). Each frequency histogram shows the result of
measurements collated from around 150 ields (three exper-
iments done on separate days, each comprising 50 ields).
The colocalization values represent the mean from the three
experiments, with the standard error of the mean. Apparent
colocalization arising from random coincidence was calcu-
lated for each image and would involve 1–2% of the pre-
mRNA molecules. This was considered to be insigniicant
and was not subtracted from the values measured. The fre-
quency values are the total from the three experiments, with
error bars showing the square root of the variance of the bi-
nomial probability that anRNA spotwill be associatedwith
the given number of protein bleaching steps.
The distribution of frequencies corresponding to the
presence of a single molecule of SRSF1 in a complex was
taken to be the same as was seen under the same conditions
but in the absence of pre-mRNA (Supplementary Figure
S1). The level of dimerization of the protein was calculated
from the proportion of complexes observed to contain two
molecules of mEGFP-SRSF1 (12%). The distributions ex-
pected from two molecules in a complex (Supplementary
Figure S1) were calculated from the proportion of SRSF1
in the extract that was labelled with mEGFP (58%) and the
level of dimerization (45,47). The level of mis-folding of the
mEGFP domain was assumed to be nil, both because it was
N-terminal to the SRSF1 moiety and because the results in
Figure 5 it the prediction for binding by two molecules of
SRSF1 in 100% of the complexes with no indication of the
presence of larger complexes.
RESULTS
The dependence of splicing on ESE sequences is linked to the
level of ESE-dependent binding by SRSF1
To test whether there was a correlation between the eficacy
of an ESE and binding of SRSF1, four different sequences
were tested: ESE-A, the known SRSF1 binding site from
Ron exon 12 (60,61); ESE-B, an SRSF1 binding motif iden-
tiied by functional SELEX (62); ESE-C, the Tra2 bind-
ing site from SMN exon 7, which has been shown to pro-
mote splicing but should not bind SRSF1 (63,64); ESE-D,
an SRSF1 motif established via RNA-seq (34). Since ESE-
A was longer than the others (14 nt), the others were in-
corporated as tandem repeats with overall lengths of 20, 24
and 16 nt, respectively. Each ESE was attached to the 3′ end
of SMN2 exon 7 in a -globin/SMN2 chimeric pre-mRNA
(47). In vitro splicing assays showed that all four ESEs in-
creased the level of splicing signiicantly, but the ESE de-
rived fromRon exon 12was by far themost effective (Figure
3A).
Transcripts labelled with Cy5 were incubated in nuclear
extract prepared from cells expressing functional mEGFP-
SRSF1 (Jobbins et al., submitted), in the presence of a 2′-O-
methyl oligonucleotide complementary to U6 snRNA that
causes spliceosome assembly to stall at complex A (45,56).
The reactions were then diluted and captured on cover slips.
The luorescentRNAand proteins were imaged using TIRF
at two or three wavelengths and luorescence was recorded
until the luorophores were bleached. Co-localized single
molecules of RNA with either protein were identiied and
the number of steps in which the mEGFP or mCherry sig-
nal bleached was recorded for each RNA molecule (Figure
2). The numbers of spots in which bleaching occurred in 1,
2, 3 etc. steps are shown as a percentage of the total num-
ber of RNA spots (Figure 3B–F). Each distribution is an
accumulation of the spots from three separate experiments.
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Figure 3. Effects of different ESE sequences on splicing and the association of SRSF1. (A) Splicing activity in vitro of pre-mRNA with different 3’ESEs.
The pre-mRNA is represented by a diagram showing the sequences from -globin exon 2 (blue), SMN2 exon 7 (brown) and the ESE under test (green). The
level of spliced mRNA (%, [mRNA]/[mRNA + pre-mRNA]) after incubation for 2 h was calculated for each of three reactions done in triplicate, and the
mean and standard error of the mean are shown. The probabilities (P) that results with the ESE-containing reactions are from the same population as the
results from the pre-mRNA lacking an extra ESE (BGSMN2) were calculated by a Student’s t test. (B) Single molecule multicolour colocalization studies
on the levels and stoichiometries of mEGFP-SRSF1 binding to molecules of labelled pre-mRNA in nuclear extracts. Histograms show the frequencies
(%) of pre-mRNA (BGSMN2) molecules showing bleaching of colocalized labelled protein in n steps (Figure 2). The number above each bar indicates
the number of complexes in which complete bleaching was achieved in 1, 2, 3, etc., steps, and hence the number of complexes in which there were 1, 2,
3, etc., molecules of luorescent fusion protein. > refers to complexes where more than 5 bleaching steps were measured; x represents complexes where
the number could not be determined. The percentage value above each histogram is the percentage of labelled pre-mRNA molecules (RNA spots) that
were associated with mEGFP-SRSF1 (Coloc. spots). Nuclear extracts contained ATP and an oligonucleotide complementary to U6 snRNA that blocks
progression beyond complex A. (C) Frequency distributions as described above for pre-mRNA comprising BGSMN2 with a 3’ESE containing one motif
of ESE-A fromRon exon 12 (60,61). The frequency for n= 1 is blue and that for n= 2 is green to assist in identifying these classes (see text). (D) As (C), but
the pre-mRNA contained two 3′-terminal repeats of an SRSF1 site of action determined by functional SELEX (62). (E) As (C), but with two 3′ terminal
repeats of the SMN2 exon 7 Tra2  binding site (63,64). (F) As (C), but with two 3′ terminal repeats of an SRSF1 site of action inferred from RNA-seq
(34).
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In the absence of an ESE, there was a strong peak of
complexes containing a singlemolecule ofmEGFP-SRSF1,
followed by a geometric distribution of higher order com-
plexes (Figure 3B, BGSMN2; Pgeo(n = 2–5) = 0.15). We have
shown elsewhere that U1 snRNPs recruit a single SRSF1
to a 5’SS in complex A but that failure to form complex
A leads to a geometric distribution associated with non-
productive complexes (Jobbins et al., submitted). We con-
clude that only a minority of BGSMN2 pre-mRNA had
assembled into complex A, while the majority had not
(see below). The addition of the ESEs reduced the lev-
els of the non-productive complexes with 3 or 4 molecules
of mEGFP-SRSF1 and produced an increase in the pro-
portion with two molecules (Figure 3C–F). Supplementary
Figure S1 shows the frequency distributions expected if all
the complexes contained either one or two molecules of
SRSF1, taking into account the proportions of labelled and
unlabelled SRSF1 in the extract and the levels of dimer-
ization observed in the absence of pre-mRNA. If all the
colocalized complexes contained two molecules of SRSF1
then, as shown in Supplementary Figure S1, the number of
molecules of RNA in complexes that bleached in two steps
would be ∼90% of the number bleaching in one step. The
ratio observed in the absence of an ESE, when many of the
molecules are in non-productive complexes, is 37% (Figure
3B), but it increases to 58% with ESE-A (Figure 3C) and is
around 40–43%with the other ESEs (Figure 3D–F)We con-
clude that the presence of an ESE reduces the proportion
of non-productive complexes and increases the proportion
of complexes containing two molecules of SRSF1. Signii-
cantly, the abundance of these complexes was highest with
the most active ESE, ESE-A, consistent with the expecta-
tion that the eficiency of an ESE is linked to its ability to
bind SRSF1. We have shown elsewhere that inclusion of an
oligonucleotide complementary to the 5′ end of U1 snRNA
eliminates the second peakwith ESE-A, demonstrating that
recruitment by U1 snRNP and the ESE are independent
(Jobbins et al., submitted).
Multiple ESEs produce additive effects on splicing but do not
increase the number of SRSF1 molecules bound
Introducing tandem repeats of ESE-A produced an increase
in the level of splicing that was proportional to the num-
ber of ESEs (Figure 4A, R2 = 0.98; Supplementary Figure
S2A), very like that seen with dsx (20) or TOES oligonu-
cleotides (42). There was a corresponding increase in the
rates and levels of formation of splicing complexes at all
stages (Figure 4B–E; Supplementary Figure S2B).
The observation of linearity is a fundamental starting
point in assessing possible pathways for ESE action. It is
clearly consistent with either the dsx mechanism (Figure
1A), if each additional protein bound were to add to a
very small probability of an interaction, but it might also
be explained by other mechanisms such as those in Fig-
ure 1B, involving multiple targets if each target contacted
has an approximately equal effect on the rate, Figure 1C, in
which binding is cooperative but each additional site occu-
pied contributes progressively less to the reduction in G,
or Figure 1D, in which the probability of binding by a pro-
tein is very low but each additional site contributes indepen-
dently.
The extent of multiple occupancy was measured for each
pre-mRNA as above. The results (Figure 5) showed that the
increase in the number of ESEs was accompanied by a small
increase in the levels of colocalization, i.e. the proportion
of pre-mRNA molecules bound. There was a roughly lin-
ear relationship between the level of co-localization and the
levels of both splicing and complex A formation (Figure 6;
A, R2 = 0.92 and Pnocorrelation < 0.001; B, R
2 = 0.89 and
Pnocorrelation < 0.05), but in both cases the intercept on the
ordinate is positive due to the binding of mEGFP-SRSF1
via U1 snRNPs and background binding.
The most striking feature of Figure 5 is that the increase
in the number of ESEs produced no increase at all in bind-
ing of three, four or ivemolecules of SRSF1, although there
was an increase in the proportion of pre-mRNA molecules
associated with two molecules of mEGFP-SRSF1. Specii-
cally, the number of complexes in which mEGFP bleached
in two steps compared to those in which it bleached in one
step rose from 58% to 71%, 75% and 81% as the number of
ESEs increased from one to four. Since the increased num-
ber of ESEs produced a clear functional effect on splicing,
it is unlikely that the apparent restriction of stable binding
to one molecule of SRSF1 results from steric occlusion of
the extra copies of the ESE by, for example, G-quadruplex
formation. However, we tested this possibility by UV cross-
linking with the ESE sequences. If only a single molecule
of SRSF1 were able to interact with the tandemly-repeated
ESEs, then the addition of an equal number of molecules
with 1, 2 3 or 4 ESEs to nuclear extract would produce equal
levels of cross-linking. However, the results showed a lin-
ear increase in cross-linking to SRSF1 and other proteins
as the number of repeats increased (Supplementary Figure
S3), meaning that there is no intrinsic barrier to protein in-
teractions with the tandem repeats.
We conclude that the afinity of SRSF1 for an ESE is low
and that the probability of binding SRSF1 is rate-limiting,
as illustrated in Figure 1D. The concurrent loss of back-
ground binding and the native gel results support the pos-
sibility that binding of the second SRSF1 strengthens the
3’SS, stimulating complexA formation. Finally, we can con-
clude that the activation step does not involve propagation
of SRSF1 (Figure 1F), although it is possible that other pro-
teins might be involved.
ESE-A increases the association of U2AF35 and U2 snRNP
To conirm that the ESE repeats affect the recruitment
of 3’SS components, the Cy5-labelled BGSMN2 and
BGSMN2 + ESE-Ax4 pre-mRNAs were incubated in com-
plex A-forming conditions in nuclear extracts containing
either mCherry-U2AF35 + mEGFP-U2AF65 or mEGFP-
U2B” (47). The results in Supplementary Figure S4 show
that the four copies of ESE-A produced a marked (about
two-fold) increase in the co-localization of U2AF and U2
snRNPs with pre-mRNA. We conclude that the single
molecule results are consistent with the results of conven-
tional experiments.
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Figure 4. Effects of multiple copies of the Ron ESE-A sequence on splicing and complex assembly. (A) The level of spliced mRNA after incubation for two
hours with BGSMN2 pre-mRNA terminating in 0, 1, 2, 3 or 4 copies of ESE-A. (B–E) Relative intensities of complexes containing labelled RNA after
analysis by native gel electrophoresis of splicing reactions containing the indicated pre-mRNA that had been incubated for the times shown.
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Figure 5. Single molecule multicolour colocalization studies on the levels and stoichiometries of mEGFP-SRSF1 binding in nuclear extracts to molecules
of BGSMN2 pre-mRNA terminating in 0, 1, 2, 3 or 4 copies of ESE-A. As in Figure 3, histograms show the frequencies (%) of pre-mRNA molecules
showing bleaching of colocalized labelled protein in n steps, and the overall proportion of pre-mRNA showing colocalization is shown at the top. (A–E),
pre-mRNA terminating in 0, 1, 2, 3 or 4 copies of ESE-A. Panels A and B are reproduced from Figure 3B and C.
A Strong ESE functions by looping to its target site
The results described above are consistent with activation
via looping, although other mechanisms are possible, such
as propagation of other proteins from SRSF1 or even some
form of sliding or reeling of a protein complex relative
to the RNA. To test these, we introduced non-RNA link-
ers between the 3’SS and ESE-Ax2 (Reichenbach et al.,
manuscript in preparation). The linkers comprised tandem
repeats of hexaethyleneglycol (HEG) or 12 (deoxy)ribose-
phosphodiester linkages of abasic DNA or abasic RNA,
which were intended to provide lexibility while disrupting
the interactions ofRNA-binding proteins thatmight propa-
gate or slide from SRSF1. Each linker was prepared by solid
phase synthesis with a portion of the 3′ exon of SMN2 exon
7 at the 5′ end and two copies of ESE-A at the 3′ end. The
linkers were attached by ligation to the body of BGSMN2.
The distance from the 3’SS to the ESE was maintained by
deleting 12 nts from the exon. The sequences removed con-
tained the Tra2 enhancer region, which is superluous in
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Figure 6. The total proportion of pre-mRNA molecules colocalized with molecules of mEGFP-SRSF1 (from all the experiments shown in Figures 3 and
5) compared with the eficiencies of splicing (A; data from Figures 3A and 4A) or complex A formation (B; data from Figure 4C, 15 min time point). Points
denoted by red diamonds were obtained with BGSMN2 with 0, 1, 2, 3 or 4 copies of ESE-A, as marked; the results with ESE-B, ESE-C and ESE-D are
shown as green, orange and blue circles, respectively.
the presence of an additional SRSF1-dependent enhancer
(42) (Psame population = 0.12; Supplementary Figure S5). The
2 × HEG linkers would be expected to be at least as lexi-
ble as the RNA sequence, since their length of ∼4.4 nm is
about eight times the persistence length (65,66) and an un-
folded RNA chain of 12 nts would have a contour length of
up to ∼7 nm, which is about 3.4 persistence lengths (67).
Splicing assays showed that the abasic RNA linker and
HEG linkers did not block the ESE, even though its activ-
ity was reduced (Figure 7A and B). In contrast, the aba-
sic DNA linker reduced splicing to the level seen in the ab-
sence of an ESE. Mass spectrometric analysis of proteins
bound to the linkers in nuclear extract showed that the aba-
sic DNA could bind known DNA damage repair proteins
(manuscript in preparation). It is possible that the recruit-
ment of these non-splicing factors interferes with ESE ac-
tivity.
We conclude from the ability of the ESE to act across a
bridge of abasic RNA or HEG, without bases or even phos-
phodiester linkages, that the bound SRprotein ismost likely
to act by looping (Figure 1E) rather than propagation of
protein complexes along the RNA or by sliding.
DISCUSSION
The results described here show that tandemly repeated
ESEs increased splicing eficiency linearly, but that only a
single molecule of SRSF1 was recruited by the ESEs in ad-
dition to the one recruited by the 5’SS-bound U1 snRNP.
The activity of the ESEs was not blocked by the introduc-
tion of non-RNA linkers between the 3’SS and the ESE.
The best explanation for these observations is that SRSF1
binds very weakly, associating only transiently with an ESE,
but that increasing the number of ESE repeats increases the
probability that a molecule of SRSF1 bound to an ESE will
interact with its target 3’SS (Figure 1D). It is this molecule
of SRSF1 that is then bound stably and detected in our ex-
periments. The interaction step is likely to be direct, involv-
ing 3D diffusion and collision (Figure 1E).
Figure 7. Effects of introducing non-RNA linkers between the 3’SS and
the ESE or a 5’SS. (A) In vitro splicing reactions done in triplicate for 2
h with pre-mRNA containing hexaethyleneglycol, abasic RNA or abasic
DNA linkers, or without a linker. In all cases, two copies of the ESE-A
motif were attached at the 3′ terminus. (B) Quantitative results from the
experiment in (A). The histogram shows the mean values and error bars
show the S.E.M.
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The results shown here demonstrate the reasons why con-
ventional, ensemble methods could not be used to test the
hypotheses described. There is a high level of apparently
non-speciic binding that follows a geometrical distribution
(e.g. Figure 3B), and the addition of ESEs has a relatively
small effect on the proportion of RNA bound by SRSF1;
instead, the distribution of numbers of molecules of SRSF1
on a molecule of pre-mRNA changes, and the geometrical
distribution shrinks in importance. On pre-mRNA with a
strong 3’SS, a similar geometric distribution is seen when
U1 binding is prevented (Jobbins et al., submitted). Thus,
single molecule measurements of binding stoichiometry en-
able novel insights. One of the limitations in our results is
that we cannot determine the exact proportion of complexes
associated with two molecules of SRF1. This is the result
of an under-representation of complexes bleaching in three
steps, which should arise from the intrinsic dimerization of
mEGFP-SRSF1 when two molecules of SRSF1 are bound
(c.f. Supplementary Figure S1). It is possible that the inter-
actions resulting in dimerization are occluded in complexA.
This limitation does not, however, affect the obvious con-
clusions that the proportions of complexes containing two
molecules of SRSF1 depend on the identity of the ESE and
increase with the number of ESE repeats.
One dificulty with single molecule methods is that their
most radical indings of necessity cannot be conirmed by
conventional methods (48). However, we have repeatedly
demonstrated that our results it those obtained previously
by ensemble methods where the strategies intersect. Ex-
amples include: our discovery that 3 molecules of PTB
are bound to either side of the repressed exon 3 of Tpm1
matched the number of potential binding sites for thismulti-
domain protein (44); the demonstration that PTB binding
sites antagonised U2AF65 binding in Tpm1 (47); the num-
bers of U1 snRNPs bound to alternative 5′ splice sites were
exactly in agreement with our earlier ribonuclease H pro-
tection assays showing that both alternative sites could be
occupied even when only one site was used (45); the inding
that in a complete three-exon transcript the difference in se-
quence between exon 7 of SMN1 and SMN2 produced a
major effect on U2 snRNP binding (47); the demonstration
that an SRSF1-dependent ESE bound SRSF1 (this work);
the observation that ESEs that stimulated splicing and com-
plex A formation also stimulated the recruitment of a U2
snRNP (this work). Thus, while ensemble methods may not
be able to directly validate single molecule results, the fact
that single molecule results can replicate the results of en-
semble methods, often with better precision, supports the
validity of the unexpected indings too.
The weakness of the initial interactions of SRSF1 with
the ESE suggests that the protein binds independently,
rather than as part of a complex such as the Tra/Tra2/SR
complex that binds dsx repeats. The Kd of SRSF1 (lack-
ing the RS domain) for an optimal site was ∼0.2 M (34),
and in functional conditions competition with other pro-
teins may reduce the rate of binding or even facilitate disso-
ciation. The transience of such interactions has interesting
implications. One is that, prior to the interactions between
a bound SR protein and 3’SS components, it seems improb-
able that stable or stoichiometrically deined complexes will
form on an exon. If other proteins behave like SRSF1, then
the multiple proteins associating with an exon are likely to
do so dynamically, binding in numerous combinations over
short periods of time. This would resolve the dilemma that
more proteins appear to be able to bind to SMN2 exon 7
and affect its splicing than could possibly bind concurrently
(68). On the other hand, this would complicate our ability
to determine which sets of proteins are consistent with ac-
tivation.
The other question that arises is in regard to cross-linking
assays, including transcriptome-wide CLIP. These will nat-
urally tend to detect SRSF1 stabilized by post-binding in-
teractions rather than molecules engaged in transient ini-
tial binding to the RNA. Thus, if multiple ESEs contribute
towards an outcome, then it is possible that only one ESE
would be bound stably on each transcript and it would be
by far the most likely to be detected. The overall signal for
that event for many molecules would be spread among all
the contributing ESEs, and the apparent signiicance of the
ESEs is likely to be under-estimated. This might have con-
tributed to the dificulty of identifying the connection be-
tween the enrichment of SRSF1 binding sites in the tran-
scriptome near 3’SS and the likelihood of skipping or in-
clusion (34,37).
The use of non-RNA linkers to differentiate between
direct through-space interactions and processive processes
(propagation or scanning) in splicing was applied irst to
determine the basis of the interaction between splice sites
across an intron (69). We used the strategy subsequently to
investigate the mechanisms of action of ESEs in a trans-
acting TOES oligonucleotide that stimulated inclusion of
SMN2 exon 7 in a three-exon pre-mRNA (70). Like the
ESE investigated here, it recruited SRSF1 and stimulated
the recruitment of U2 snRNP and associated proteins (42).
However, the hexaethyleneglycol linker was inserted via
copper-catalyzed alkyne-azide cycloaddition (CuAAC) lig-
ation, forming exclusively a 1,4-triazole between the anneal-
ing domain and the ESE domain. The activity of the TOES
oligonucleotide was actually increased by the inclusion of
one or two units of hexaethylene glycol, but this improve-
ment was lost if ten, eleven or twenty units were included,
which is consistent with interactions by diffusion (70). The
work described here with 3’ESE sequences that act in cis
conirms that intervening non-RNA linkers do not prevent
the activation of a 3’SS by an ESE. Our conclusion that the
activation step involves looping is in agreement with that
of Shen &Green (2004), who used anMS2-tethered RS do-
main with an intervening TEV cleavage site to show that the
RS domain tethered to the 3′ exon could be cross-linked to
the branch site in complex A (38).
A different outcome was found when we tested the effects
of a non-RNA linker on a 5’ESE that affects 5’SS selection
(71). The activity of the 5’ESE was ablated by inclusion of
hexaethyleneglycol, inserted via CuAAC ligation between
the ESE and the exon upstream of the target 5’SS. It is hard
to resist the inference that the effects of an ESE on a 5′ splice
site are mediated by a process involving contact with the in-
tervening RNA, and thus are quite different from the loop-
ing process in which an ESE activates a 3’SS. The possibility
that these are quite different processes is in agreement with
the observations that the ability of SRSF1 to stimulate U1
snRNP binding to a 5’SS does not require the RS domain
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky056/4829697
by University of Strathclyde user
on 05 February 2018
12 Nucleic Acids Research, 2018
(61,72,73), whereas the tethering experiments have shown
that the activation step for 3’SSs requires only the RS do-
main (19,38). It remains to be seen whether such differences
are characteristic of the mechanisms by which ESEs affect
5’SSs as opposed to 3’SSs or whether there are other impor-
tant determinants of the activation step mechanism.
The picture that emerges from these experiments is that
SRSF1 binds transiently to SRSF1-dependent ESEs, and
that eachESEmakes an independent but effectively additive
contribution to the probability that one SRSF1 molecule
will be locked into place in complex A by interactions with
other components of the early splicing complexes. It is not
clear yet to what extent this new model applies to the many
other proteins that interact with exons. It has been estimated
that most positions in a short exon contribute signiicantly
to the outcome of splicing (25,27,74) and that mutations
act independently and additively (74,75). This is consistent
with the possibility thatmost interacting proteins bind tran-
siently (74), as we have inferred for SRSF1, and that the
exon–protein complex is in a state of rapid lux. If so, it may
be that none of the many possible combinations of proteins
bound to the exon is uniquely required for activation. If re-
pressor proteins behave similarly and are purely competitive
antagonists, then even an exon with a heavy preponderance
of silencers would be bound eventually by an SR protein
and make contact with the 3′ splice site. To prevent this,
there may be a time limit, creating a window of opportu-
nity within which an ESE-bound SR protein might contact
the 3′ splice site. The limit might be imposed by the slower
formation of stable repressor complexes, such as those of
PTBP1 around Tpm1 exon 3 (44) or exon N1 of Src (76), or
of Rbfox in LASR complexes (77), or more generally by a
transition into an alternative pathway, both in vivo and in
vitro. The existence and nature of any limiting events have
yet to be determined.
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